Streetbeat News

Analyst Ratings

CNHI

UBS analyst Steven Fisher has maintained a Buy rating on CNH Industrial (NYSE:CNHI) but has reduced the price target from $20 to $15.

Portfolio Pulse from Benzinga Newsdesk

November 24, 2023 | 3:57 pm

AAPL

Wedbush analyst Daniel Ives has reiterated an Outperform rating on Apple Inc. (NASDAQ:AAPL) and maintained a price target of $240. The reaffirmation of the positive outlook suggests confidence in Apple's future performance.

Portfolio Pulse from Benzinga Newsdesk

November 24, 2023 | 3:52 pm

BF

BF/B

Wedbush analyst Gerald Pascarelli has maintained a Neutral rating on Brown-Forman (NYSE:BF) and reduced the price target from $70 to $65.

Portfolio Pulse from Benzinga Newsdesk

November 24, 2023 | 3:46 pm

BRBR

Truist Securities analyst Bill Chappell has reaffirmed a Buy rating on BellRing Brands (NYSE:BRBR) and increased the price target from $45 to $55.

Portfolio Pulse from Benzinga Newsdesk

November 24, 2023 | 3:43 pm

GNLX

Benchmark analyst Bruce Jackson has maintained a Speculative Buy rating on Genelux Corporation (NASDAQ:GNLX) but has reduced the price target from $38 to $30.

Portfolio Pulse from Benzinga Newsdesk

November 24, 2023 | 3:41 pm

MSFT

Mizuho analyst Gregg Moskowitz has reiterated a Buy rating on Microsoft (NASDAQ:MSFT) and maintained a price target of $420.

Portfolio Pulse from Benzinga Newsdesk

November 24, 2023 | 3:38 pm

MSFT

RBC Capital analyst Rishi Jaluria has reiterated an Outperform rating on Microsoft (NASDAQ:MSFT) and maintained a price target of $390.

Portfolio Pulse from Benzinga Newsdesk

November 24, 2023 | 3:37 pm

SR

RBC Capital analyst Shelby Tucker has maintained a 'Sector Perform' rating on Spire Inc. (NYSE:SR) but has reduced the price target from $66 to $65.

Portfolio Pulse from Benzinga Newsdesk

November 24, 2023 | 3:35 pm

TCBI

RBC Capital analyst Jon Arfstrom has maintained a 'Sector Perform' rating on Texas Capital Bancshares (NASDAQ:TCBI) but has reduced the price target from $66 to $61.

Portfolio Pulse from Benzinga Newsdesk

November 24, 2023 | 3:33 pm

HCM

Hutchmed's stock is experiencing an uptick following an upgrade from Deutsche Bank, which changed its rating from Hold to Buy and increased the price target from $20 to $22.1.

Portfolio Pulse from Benzinga Newsdesk

November 24, 2023 | 3:31 pm